Vera Therapeutics, Inc.VERA
Price (close)
$33.34
Market cap
$2.4B
P/E
—
Revenue (TTM)
—
Net income
-$401.9M
Dividend yield
—
1-year total return
23.7%
Net margin
—
Revenue growth
—
Debt / equity
0.18x
What Vera Therapeutics, Inc. does.
No business description on file yet.
Revenue and profit, by fiscal year.
| Fiscal year | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Net income | -$53.4M | -$32.6M | -$89.1M | -$96.0M | -$152.1M | -$299.6M |
| Free cash flow | -$34.9M | -$23.7M | -$67.7M | -$92.2M | -$135.7M | -$241.7M |
More on VERA.
- Vera Therapeutics, Inc. summary
- Vera Therapeutics, Inc. financial statements
- Vera Therapeutics, Inc. key metrics
- Vera Therapeutics, Inc. health scores and style box
- Vera Therapeutics, Inc. earnings
- Vera Therapeutics, Inc. dividends
- Vera Therapeutics, Inc. valuation
- Vera Therapeutics, Inc. ownership and insiders
- Vera Therapeutics, Inc. peers
Figures from Vera Therapeutics, Inc.'s filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.